Raising testosterone: TRT vs enclomiphene vs hCG vs kisspeptin

Reviewed 17 sourcesPublished by PepVault

TRT, enclomiphene, hCG and kisspeptin compared: what each does to LH, testosterone and sperm, what the trials measured, and which are approved.

A man in a grey tank top doing a farmer’s carry with two kettlebells across a lawn
Last reviewed
Sources
17
Questions
8
Compounds
4

The short answer

TRT adds testosterone from outside and works whatever the cause, but it suppresses your own LH and, with it, sperm production. Enclomiphene and hCG raise your own testosterone: enclomiphene makes the pituitary send more LH and kept sperm normal in its trials; hCG stands in for LH and kept sperm going in men on TRT. Kisspeptin is still experimental. Two low morning tests and a doctor come first.

Every number checked at its primary source · · 17 sources · How we research

Evidence: TRT: large randomized trials and FDA labels. Enclomiphene: phase 2 and 3 trials of blood levels and sperm, not symptoms. hCG: an FDA label and small studies. Kisspeptin-10: short studies in small groups of healthy men.

A man in a grey tank top doing a farmer’s carry with two kettlebells across a lawn

What does each one do to LH, testosterone and sperm?

Testosterone is made in the testes on an order that comes down a chain. The hypothalamus sends GnRH (gonadotropin-releasing hormone); the pituitary answers with LH (luteinizing hormone), which tells the testes to make testosterone, and FSH (follicle-stimulating hormone), which with that testosterone drives sperm production. Each option enters the chain at a different link, and that one fact decides what it does to fertility.

OptionWhere it actsYour own LHTestosteroneSpermUS status (November 2026)
TRT (testosterone itself)Replaces the end productFalls1Raised to the level the doctor targetsFalls: weekly shots stopped sperm in most fertile men within 6 months4Approved for low testosterone with a known cause; a Schedule III controlled drug1
Enclomiphene (a pill)The brain's estrogen sensorRises67Rose to gel's level67; pooled with clomiphene, 274 ng/dL above placebo8Kept in the normal range, where gel lowered it7Not approved: FDA letter 2015, EU refusal 2018910
hCG (an injection)The testes, standing in for LHFalls, while hCG does LH's job12Rose about 150% in older men over 3 months12Kept steady in men on TRT13Approved for selected men whose low testosterone starts in the pituitary11
Kisspeptin-10 (an infusion in studies)The top of the chain, releasing GnRHRises within 30 minutes14Rose during a day-long infusion14Not measured yetExperimental; no US-approved product

The winner depends on the question. For the highest, steadiest level, and for testes that no longer respond, TRT is the one that works. For a man who wants children, the three that raise his own production keep sperm going, and enclomiphene is the one with phase 3 data showing it. hCG and enclomiphene get their full fertility head-to-head in our guide to hCG vs hMG vs enclomiphene.

A smiling woman in a blue top leaning on her kitchen counter with her phone and a notebook

PepVault for iPhone

Keep your protocol in PepVault

PepVault logs each shot or pill with a reminder, and its bloodwork section keeps your testosterone, LH, FSH, estradiol and hematocrit results over time.

Download on the App Store

7 days free on the yearly plan for new subscribers.

How well does TRT work, and is it safe for the heart?

TRT, testosterone replacement therapy, gives the hormone itself by injection, gel or other forms. It is the only option of the four that works when the testes themselves have failed, because it does not need them to make anything1. In the Testosterone Trials, 790 men aged 65 or older with levels under 275 ng/dL used gel or placebo for a year: testosterone gave a moderate gain in sexual activity, desire and erections and slightly better mood, but no gain in energy (vitality) or walking distance3.

The heart question now has a large answer. TRAVERSE randomized 5,246 men aged 45 to 80 with low testosterone and heart disease or a high risk of it to testosterone gel or placebo. Heart attack, stroke or cardiovascular death occurred in 7.0% on testosterone and 7.3% on placebo over a mean 33 months of follow-up, which met the trial's preset test that testosterone was no worse than placebo (non-inferiority)2. Atrial fibrillation (an irregular heartbeat), acute kidney injury and pulmonary embolism (a clot in the lung) were more common on testosterone2.

The cypionate label adds three checks: testosterone can raise blood pressure, which can raise cardiovascular risk over time, so blood pressure is checked periodically (in 2025 the FDA found the rise across all testosterone products and had TRAVERSE's results added to every label17); hemoglobin and hematocrit (the share of the blood that is red cells) should be checked for a rise; and safety and benefit in men whose levels fell only with age have not been established1. The injected ester has a half-life of about eight days, so weekly shots build up over the first weeks1.

Try it

How Testosterone Cypionate builds up

An estimate from a half-life of about 8 days, one dose a week for four weeks. The shape of the level, not a measurement.

Try your own schedule

Why does TRT stop sperm production?

Outside testosterone tells the pituitary there is plenty, so it cuts LH and, at large doses, FSH1. The testes lose their order to make testosterone inside themselves, and sperm production slows. The effect is reliable enough to have been tested as male birth control: in a WHO study of 271 healthy fertile men on 200 mg of testosterone enanthate a week, 157 reached zero sperm, a cumulative 65% at six months, taking 120 days on average4.

It reversed. After the shots stopped, sperm counts reached 20 million per mL in a median of 3.7 months and the men's own starting levels in 6.7 months4. Those were young fertile men on a fixed course; recovery after years of TRT is a separate question that study did not answer.

How does enclomiphene raise your own testosterone?

Enclomiphene is a SERM (a selective estrogen receptor modulator) and one of the two forms (isomers) mixed together in the fertility drug clomiphene6. It blocks estrogen's feedback signal in the brain, so the pituitary reads estrogen as low and sends out more LH and FSH, and the testes make more testosterone and sperm on their own.

In a meta-analysis of randomized trials that pooled enclomiphene with clomiphene, the two together raised total testosterone by 274 ng/dL over placebo, with LH up 4.7 IU/L and FSH up 4.6 IU/L, and testosterone was not significantly different from testosterone gel8. The sperm result is the striking one. In a small trial in men coming off gel, enclomiphene lifted sperm counts in seven of seven men at three months and six of six at six months, in a range of 75 to 334 million per mL, while at three months the gel left all five men under 20 million6. Two phase 3 trials in overweight men found the same pattern: enclomiphene held sperm concentration in the normal range, and the gel brought a marked drop7.

Two limits. Testosterone fell back to its starting level one month after enclomiphene stopped6, so it works only while taken. And it is not approved in the US or the EU: the FDA's 2015 letter said its phase 3 design was no longer adequate to show clinical benefit, and the EU's 2018 refusal noted the trials did not look at symptoms such as libido or bone strength and cited a risk of blood clots in the veins910.

What does hCG do, alone or with TRT?

hCG (human chorionic gonadotropin) is the pregnancy hormone, and its action is virtually identical to LH: it tells the Leydig cells of the testes to make testosterone11. Because it skips the brain, it works when the pituitary is the broken link, which is the use its label names in men11.

On its own, it raises testosterone firmly. In 40 men over 60 with testosterone at or below 15 nmol/L, twice-weekly shots for three months raised total and free testosterone by about 150%, added about 2 kg of lean mass and took off about 1 kg of fat, with no gain in strength; their own LH and FSH fell and testis volume dropped by about 5 mL12. Alongside TRT, a low dose keeps the testes working: in 26 men on TRT plus 500 IU every other day, testosterone rose from 207 to 1,055 ng/dL, semen measures did not change during follow-up, none reached zero sperm, and nine fathered a pregnancy13. The label notes it can sporadically cause breast tissue growth (gynecomastia)11.

Is kisspeptin a real option yet?

Kisspeptin is the switch at the very top of the chain: it makes the hypothalamus release GnRH. Kisspeptin-10 is its shortest fully active piece. In healthy men, one intravenous dose lifted LH from 4.1 to 12.4 IU/L within 30 minutes, and a 22.5-hour infusion took testosterone from 16.6 to 24.0 nmol/L14.

Timing is the catch. In a 2026 study, a nonstop five-day infusion under the skin kept testosterone up but let LH and FSH slide back to placebo levels, while eight hours on and sixteen off held the LH rise for 12 days15. Both studies used infusions in small groups of healthy men, not shots people give themselves, and measured hormones, not sperm or symptoms. A phase 2 trial of kisspeptin under the skin in people with idiopathic hypogonadotropic hypogonadism (low LH and FSH with no known cause) is recruiting16.

Kisspeptin needs working GnRH cells and a working pituitary below it, so it shares enclomiphene's limit: it cannot help testes or a pituitary that cannot answer.

What do people on each one report?

Commonly reported: on TRT, more energy, steadier mood and a stronger libido once levels settle, with acne, oily skin and a rising hematocrit as the side effects most talked about; on hCG, testes that keep their size on TRT, and nipple tenderness for some at higher doses; on enclomiphene, a lift in energy and libido over a few weeks; on kisspeptin-10, effects many describe as subtle or short-lived.

How do you find out which one fits you?

Starting any of the four is a decision for a doctor who has your blood results. These steps get you to that conversation with the numbers that decide it.

  1. Have total testosterone measured on a fasting morning with an accurate lab test5.
  2. Repeat it on another morning. The guideline confirms low testosterone only when it is consistently low, and the cypionate label asks for two low morning results on separate days before starting15.
  3. Ask for LH and FSH with the repeat. High LH means the testes are not answering, and only TRT works there; low or normal LH means the order from above is short, the group enclomiphene was tested in and the hCG label names711.
  4. Say whether you want children in the next year or two. The Endocrine Society recommends against starting TRT in men planning fertility in the near term5.
  5. If you start TRT, expect testosterone, hematocrit and prostate checks during the first year, and blood pressure checks along the way15.

PepVault logs each shot or pill with a reminder, and its bloodwork section keeps your testosterone, LH, FSH, estradiol and hematocrit results over time. Log it in PepVault

When to get help Sudden shortness of breath, or a leg that turns painful, swollen, warm and red, is a reason to get care the same day; the testosterone label lists both as signs of a clot1.

Track it in the app

Sources

  1. Depo-Testosterone (testosterone cypionate) prescribing information, Pfizer (revised October 2025). DailyMed, published Nov 13, 2026. dailymed.nlm.nih.gov
  2. Lincoff AM et al. Cardiovascular safety of testosterone-replacement therapy (TRAVERSE). N Engl J Med. 2023. PubMed 37326322
  3. Snyder PJ et al. Effects of testosterone treatment in older men (the Testosterone Trials). N Engl J Med. 2016. PubMed 26886521
  4. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet. 1990. PubMed 1977002
  5. Bhasin S et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018. PubMed 29562364
  6. Kaminetsky J et al. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. J Sex Med. 2013. PubMed 23530575
  7. Kim ED, McCullough A, Kaminetsky J. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone (ZA-304 and ZA-305). BJU Int. 2016. PubMed 26496621
  8. Hohl A et al. Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials. Arch Endocrinol Metab. 2025. PubMed 41066380
  9. Repros Therapeutics. Repros receives complete response letter from FDA for enclomiphene. Form 8-K press release, Dec 1, 2015. sec.gov
  10. European Medicines Agency. EnCyzix (enclomifene): refusal of the marketing authorisation, 2018. ema.europa.eu
  11. Pregnyl (chorionic gonadotropin) prescribing information, Organon (revised March 2025). DailyMed, published Dec 4, 2025. dailymed.nlm.nih.gov
  12. Liu PY, Wishart SM, Handelsman DJ. A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. J Clin Endocrinol Metab. 2002. PubMed 12107212
  13. Hsieh TC et al. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013. PubMed 23260550
  14. George JT et al. Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab. 2011. PubMed 21632807
  15. Yeung AC et al. Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men. Eur J Endocrinol. 2026. PubMed 42549827
  16. Kisspeptin administration subcutaneously to patients with IHH. ClinicalTrials.gov NCT05896293 (Massachusetts General Hospital; phase 2, recruiting). clinicaltrials.gov
  17. U.S. Food and Drug Administration. FDA issues class-wide labeling changes for testosterone products. February 28, 2025. fda.gov

Newsletter · Weekly

The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

We’ll email you a link to confirm. Your address is used for the briefing only. Privacy

PepVault for iPhone

Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo